You have 9 free searches left this month | for more free features.

benchmark

Showing 1 - 25 of 756

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lung Cancer, Lung Non-Small Cell Carcinoma, Lung; Node Trial in Bologna (Tornado (Cook))

Recruiting
  • Lung Cancer
  • +2 more
  • Tornado (Cook)
  • Bologna, Emilia Romagna, Italy
    Gian Piero Bandelli
Apr 5, 2023

COVID-19, Influenza Trial in United States (Lucira COVID-19 & Flu Test)

Completed
  • COVID-19
  • Influenza
  • Lucira COVID-19 & Flu Test
  • Cullman, Alabama
  • +6 more
Nov 16, 2023

Parkinson Disease Trial in Durham (Interdisciplinary Visit)

Completed
  • Parkinson Disease
  • Interdisciplinary Visit
  • Durham, North Carolina
    Duke University
Apr 14, 2022

Atopic Diathesis, Eczema-prone Skin Trial in Schenefeld (Atopi intensive care BNO 3731, Benchmark product)

Completed
  • Atopic Diathesis
  • Eczema-prone Skin
  • Atopi intensive care BNO 3731
  • Benchmark product
  • Schenefeld, Germany
    SGS proderm GmbH
Mar 28, 2023

Atopic Diathesis, Eczema-Prone Skin Trial in Schenefeld (Lotion BNO 3732, Body Lotion Benchmark product)

Completed
  • Atopic Diathesis
  • Eczema-Prone Skin
  • Lotion BNO 3732
  • Body Lotion Benchmark product
  • Schenefeld, Germany
    SGS proderm GmbH
Mar 27, 2023

HIV Trial in Thika (co-formulated 25mg TAF/ 200mg FTC)

Recruiting
  • HIV Infections
  • co-formulated 25mg TAF/ 200mg FTC
  • Thika, Kenya
    Kenya Medical Research Institute - Partners in Health Research a
Jan 24, 2023

COVID-19 Trial in United States (NVX-CoV2373, SARS-CoV-2 rS antigen/Matrix-M Adjuvant)

Active, not recruiting
  • COVID-19
  • NVX-CoV2373
  • SARS-CoV-2 rS antigen/Matrix-M Adjuvant
  • Austin, Texas
  • +4 more
May 16, 2023

Norovirus Infections Trial in Cypress, New Orleans, Austin (VXA-GI.1.NN, Placebo Tablet)

Completed
  • Norovirus Infections
  • VXA-GI.1.NN
  • Placebo Tablet
  • Cypress, California
  • +2 more
Sep 19, 2022

Low Back Pain Trial in Nashville (VR Pain Education, Usual Care Physical Therapy)

Completed
  • Low Back Pain
  • VR Pain Education
  • Usual Care Physical Therapy
  • Nashville, Tennessee
    Belmont University
Feb 1, 2023

Smoking Trial in United States (THS 2.2, CC)

Completed
  • Smoking
  • THS 2.2
  • CC
  • Tempe, Arizona
  • +18 more
Jan 25, 2023

SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)

Active, not recruiting
  • SARS-CoV-2
  • mRNA-1273.211
  • +6 more
  • Sacramento, California
  • +22 more
Nov 16, 2022

SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)

Active, not recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1073
  • +3 more
  • Hollywood, Florida
  • +13 more
Oct 5, 2022

HIV Trial in Thika (co-formulated 300 mg TDF/ 200mg FTC)

Enrolling by invitation
  • HIV Infections
  • co-formulated 300 mg TDF/ 200mg FTC
  • Thika, Kenya
    Kenya Medical Research Institute - Partners in Health Research a
Jun 2, 2022

Smoking Cessation Trial in Sacramento, Metairie, Austin (X-22 Smoking Cessation Product, Active Control Cigarettes)

Completed
  • Smoking Cessation
  • X-22 Smoking Cessation Product
  • Active Control Cigarettes
  • Sacramento, California
  • +2 more
Oct 21, 2021

Hemorrhoids Trial in Yerevan (Anusol, Relief [Name], Placebo)

Completed
  • Hemorrhoids
  • Yerevan, Armenia
  • +1 more
Aug 12, 2022

Commercial Typhoid Tests Validation Trial

Completed
  • Typhoid Fever
  • Rapid diagnostic tests
  • Nairobi, Kenya
  • +1 more
May 23, 2022

SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)

Recruiting
  • SARS-CoV-2
  • Influenza
  • Fluarix
  • +8 more
  • Chandler, Arizona
  • +68 more
Apr 24, 2023

COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))

Not yet recruiting
  • COVID-19
  • XBB.1.5 Vaccine (Booster)
  • XBB.1.5 Vaccine (single dose)
  • Mobile, Alabama
  • +29 more
Aug 4, 2023

Influenza Trial in United States (FluBlokĀ®, Placebo)

Completed
  • Influenza
  • FluBlokĀ®
  • Placebo
  • Beverly Hills, California
  • +23 more
Mar 24, 2022

Acute Respiratory Infection, Telehealth Trial in Dallas (Trending Feedback, Benchmark Peer Comparison Feedback, Private

Enrolling by invitation
  • Acute Respiratory Infection
  • Telehealth
  • Trending Feedback
  • +3 more
  • Dallas, Texas
    Teladoc Health
Mar 28, 2022

Pneumococcal Vaccines Trial in United States (24 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate

Active, not recruiting
  • Pneumococcal Vaccines
  • 24 valent pneumococcal conjugate vaccine
  • 20 valent pneumococcal conjugate vaccine
  • Hollywood, Florida
  • +12 more
Jul 25, 2022

Heart Failure Trial in Southampton (Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronisation Therapy

Not yet recruiting
  • Heart Failure
  • Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronisation Therapy Defibrillator (CRTD)
  • Southampton, Hampshire, United Kingdom
    Southampton Clinical Trials Unit
Oct 6, 2022

Pneumococcal Vaccines Trial in United States (31 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate

Recruiting
  • Pneumococcal Vaccines
  • 31 valent pneumococcal conjugate vaccine
  • 20 valent pneumococcal conjugate vaccine
  • Mobile, Alabama
  • +24 more
Nov 20, 2023

COVID-19, SARS-CoV-2 Infection Trial in United States (NVX-Cov2373)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • Long Beach, California
  • +30 more
Jul 18, 2022

Severe Traumatic Brain Injury Trial in Worldwide (ICP, CREVICE)

Not yet recruiting
  • Severe Traumatic Brain Injury
  • ICP
  • CREVICE
  • Seattle, Washington
  • +8 more
Oct 1, 2022